CorMedix Inc.
Ticker: 1410098
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 54.52-46.5% | 101.93-20.0% | 127.43+22.2% | 104.28+162.4% | 39.74+1.7% | 39.08+241.0% | 11.46+1314.8% | 0.81 |
| Total Income | 54.52-46.5% | 101.93-20.0% | 127.43+22.2% | 104.28+162.4% | 39.74+1.7% | 39.08+241.0% | 11.46+1314.8% | 0.81 |
| EXPENSES | ||||||||
| Expenditure | 61.14+3.6% | 59.02-7.4% | 63.77+20.5% | 52.93+162.2% | 20.19+6.5% | 18.96+28.6% | 14.74-8.5% | 16.11 |
| Tax | -1.73-113.6% | 12.75-25.2% | 17.04+130.4% | -55.99-10867.3% | 0.52 | — | — | — |
| PROFIT | ||||||||
| PBT | -16.45-142.5% | 38.73-30.4% | 55.65+5.8% | 52.58+158.4% | 20.35-1.4% | 20.64+842.4% | -2.78+80.4% | -14.15 |
| Net Profit | -14.72-156.6% | 25.99-32.7% | 38.60-64.4% | 108.56+447.5% | 19.83-3.9% | 20.64+842.4% | -2.78+80.4% | -14.15 |
| KEY METRICS | ||||||||
| OPM % | -12.14%-54.24pp | 42.10%-7.86pp | 49.96%+0.72pp | 49.24%+0.06pp | 49.18%-2.31pp | 51.49%+80.19pp | -28.70%+71.30pp | -100.00% |
| NPM % | -27.00%-52.50pp | 25.50%-4.80pp | 30.29%-69.71pp | 100.00%+50.10pp | 49.90%-2.92pp | 52.82%+77.06pp | -24.24%+75.76pp | -100.00% |
| EPS | -0.19-157.6% | 0.33-31.2% | 0.48-66.2% | 1.42+389.7% | 0.29-9.4% | 0.32+740.0% | -0.05+80.0% | -0.25 |
Corporate Events
Board MeetingCRMD
202629Jun
Board Meeting
Executive leadership structure change: Elizabeth Hurlburt ap…
SEC Filing ↗ Board MeetingCRMD
202623Jun
Board Meeting
CorMedix Inc. held its 2026 Annual Meeting of Stockholders t…
SEC Filing ↗